Evidence mapPaperPMID 42535792Full record

ArticleeLife2026

Decoupling AMPK from fatty acid synthesis allows maintenance of fitness late in life.

Hanane Hadj-Moussa, Megan Ulusan, Dorottya Horkai, Mohammed Kamran Afzal Mirza, Jonathan Houseley

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hanane Hadj-MoussaEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-3338-9046
Megan UlusanEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID https://orcid.org/0009-0001-0569-3403
Dorottya HorkaiEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-9430-1864
Mohammed Kamran Afzal MirzaEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID https://orcid.org/0009-0008-2467-4882
Jonathan HouseleyEpigenetics Programme, Babraham Institute, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-8509-1500

Funding

Biotechnology and Biological Sciences Research Council 1947502Biotechnology and Biological Sciences Research Council BBS/E/B/000C0523Engineering and Physical Sciences Research Council EP/Y027892/1
6 · The paper itself

Abstract

Although lifespan has long been the focus of ageing research, preventing functional decline late in life is a more pressing societal need. Here, we investigate the basis of senescence and declining fitness during replicative ageing in budding yeast, and describe a metabolic perturbation that preserves late-life fitness even on an unrestricted glucose diet. We show that senescence can be prevented by constitutive activation of AMPK, though only for approximately half the ageing population, and use genetic and functional assays to link this heterogeneous response with differences in cytosolic acetyl coenzyme A (Acetyl-CoA) metabolism. In one class of ageing cell, AMPK activity maintains fitness late in life through pathways that transport cytosolic Acetyl-CoA into mitochondria, but AMPK also inhibits fatty acid synthesis which leads to lipid starvation in the other class of ageing cell. Therefore, AMPK activity has both positive and negative effects, but we show that constitutive AMPK activity uncoupled from fatty acid synthesis inhibition (the A2A mutant) suppresses senescence and maintains fitness in both classes of ageing cell. Our findings support a model in which lipid starvation and excess Acetyl-CoA availability are major drivers of senescence in replicatively aged wild-type yeast. This work shows that ageing is not intrinsically associated with declining fitness, at least in yeast, and that re-engineering highly conserved metabolic pathways allows fitness to be preserved very late in life.

Indexed as

AMP-Activated Protein KinasesFatty AcidsSaccharomyces cerevisiaeAcetyl Coenzyme AAcetyl Coenzyme AAMP-Activated Protein KinasesFatty Acidsacetyl coenzyme AageingAMPKcell biologyhealthspanlipid synthesismetabolismS. cerevisiae

Identifiers

PMID42535792
PMCPMC13427345

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.